Karakus A

References (5)

Title : Novel hydrazones derived from anthranilic acid as potent cholinesterases and alpha-glycosidase inhibitors: Synthesis, characterization, and biological effects - Tokali_2023_J.Biochem.Mol.Toxicol__e23521
Author(s) : Tokali FS , Taslimi P , Taskin-Tok T , Karakus A , Sadeghian N , Gulcin I
Ref : J Biochem Mol Toxicol , :e23521 , 2023
Abstract : Tokali_2023_J.Biochem.Mol.Toxicol__e23521
ESTHER : Tokali_2023_J.Biochem.Mol.Toxicol__e23521
PubMedSearch : Tokali_2023_J.Biochem.Mol.Toxicol__e23521
PubMedID: 37706603

Title : Novel Quinazolinone Derivatives: Synthetic Analogues for the Treatment of Glaucoma, Alzheimer's Disease and Diabetes Mellitus - Tokali_2023_Chem.Biodivers__e202301134
Author(s) : Tokali FS , Taslimi P , Tuzun B , Karakus A , Sadeghian N , Gulcin I
Ref : Chem Biodivers , :e202301134 , 2023
Abstract : Tokali_2023_Chem.Biodivers__e202301134
ESTHER : Tokali_2023_Chem.Biodivers__e202301134
PubMedSearch : Tokali_2023_Chem.Biodivers__e202301134
PubMedID: 37695993

Title : New 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and alpha-glucosidase enzymes - Mohammadi-Khanaposhtani_2022_Arch.Pharm.(Weinheim)__e2100313
Author(s) : Mohammadi-Khanaposhtani M , Nori M , Valizadeh Y , Javanshir S , Dastyafteh N , Moaazam A , Hosseini S , Larijani B , Adibi H , Biglar M , Hamedifar H , Mahdavi M , Kamci H , Karakus A , Taslimi P
Ref : Arch Pharm (Weinheim) , :e2100313 , 2022
Abstract : Mohammadi-Khanaposhtani_2022_Arch.Pharm.(Weinheim)__e2100313
ESTHER : Mohammadi-Khanaposhtani_2022_Arch.Pharm.(Weinheim)__e2100313
PubMedSearch : Mohammadi-Khanaposhtani_2022_Arch.Pharm.(Weinheim)__e2100313
PubMedID: 35132681

Title : Cases of organophosphate poisoning treated with high-dose of atropine in an intensive care unit and the novel treatment approaches - Karakus_2012_Toxicol.Ind.Health_30_421
Author(s) : Karakus A , Celik MM , Karcioglu M , Tuzcu K , Erden ES , Zeren C
Ref : Toxicol Ind Health , 30 :421 , 2012
Abstract : Karakus_2012_Toxicol.Ind.Health_30_421
ESTHER : Karakus_2012_Toxicol.Ind.Health_30_421
PubMedSearch : Karakus_2012_Toxicol.Ind.Health_30_421
PubMedID: 23012340

Title : Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial - van Eijk_2010_Lancet_376_1829
Author(s) : van Eijk MM , Roes KC , Honing ML , Kuiper MA , Karakus A , van der Jagt M , Spronk PE , van Gool WA , van der Mast RC , Kesecioglu J , Slooter AJ
Ref : Lancet , 376 :1829 , 2010
Abstract : van Eijk_2010_Lancet_376_1829
ESTHER : van Eijk_2010_Lancet_376_1829
PubMedSearch : van Eijk_2010_Lancet_376_1829
PubMedID: 21056464